David Deming's most recent trade in Phio Pharmaceuticals Corp was a trade of 14,000 Common Stock, $.0001 par value done . Disclosure was reported to the exchange on Sept. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharma Corp | Deming H. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 14,000 | 14,000 (0%) | 0% | 0 | Common Stock, $.0001 par value | |
| PetVivo Holdings Inc | David Deming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 6,373 | 6,373 | - | - | Employee Stock Option (right to buy) | |
| PetVivo Holdings Inc | David Deming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 14,778 | 29,890 | - | 0 | Common Stock |